Breaking News

Operator of Dairy Queen franchises fined $42K after federal investigation finds child labor violations at 11 Indiana, Michigan, locations US Department of Labor awards $4.5M in funding to support continued clean-up, recovery efforts after western Oregon’s 2020 wildfires Findings of the Independent International Commission of Inquiry on Ukraine | Press Release US Department of Labor awards nearly $199M in Quality Jobs, Equity, Strategy, Training Disaster Recovery grants Administrator Samantha Power Tests Positive for COVID-19 | Press Release NASA’s DART Mission Hits Asteroid in First-Ever Planetary Defense Test Governor Newsom Signs Legislation to Protect Animal Welfare 9.26.22 Additional Municipalities Can Now Apply for FEMA Assistance due to Hurricane Fiona

Issued: London

These matters relating to our operations in China were deeply disappointing to GSK. They have previously been the subject of investigation by authorities in China and the United States. GSK cooperated fully with those investigations, which have since concluded and been resolved. GSK is committed to operating its commercial activities in an ethical and professional manner consistent with the Company’s values. Over the last few years, GSK has made significant changes to its commercial practices globally, which include changes to the way the Company’s sales representatives are compensated and stopping payments to Healthcare Practitioners to speak to other providers about its products.

More information on our business model changes is available here:

Source link